PDL BioPharma (PDLI) revises its Q2 revenue guidance to ~$122M, down from prior guidance of $128M, due to a mathematical error made on the earlier guidance. Shares -1.5%. (PR)
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Nasdaq.com (Mon, 11:09AM)
at Nasdaq.com (Mon, 9:00AM)
at Benzinga.com (Mon, 6:04PM)
at Nasdaq.com (Dec 29, 2014)
at Nasdaq.com (Dec 2, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs